SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-001488
Filing Date
2024-01-04
Accepted
2024-01-04 07:11:55
Documents
14
Period of Report
2024-01-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20240104.htm   iXBRL 8-K 41170
2 EX-99.1 axsm-ex99_1.htm EX-99.1 106361
3 GRAPHIC img36028404_0.jpg GRAPHIC 22496
  Complete submission text file 0000950170-24-001488.txt   306642

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axsm-20240104.xsd EX-101.SCH 2451
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axsm-20240104_lab.xml EX-101.LAB 12798
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axsm-20240104_pre.xml EX-101.PRE 9441
8 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20240104_htm.xml XML 4543
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 24509749
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)